Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24945,877,1.00 [0.93-1.08],0.9505814626596986
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24971,132,1.00 [0.82-1.22],0.98889701922666
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26507,148,0.96 [0.79-1.16],0.6661225098544651
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19830,479,0.98 [0.88-1.09],0.654362878127025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26446,87,0.85 [0.66-1.10],0.2135797524003805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25756,76,0.80 [0.61-1.06],0.1202013822385863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27460,86,0.87 [0.68-1.12],0.2819279385876594
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27480,60,0.84 [0.62-1.14],0.2546065779838157
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25216,46,1.23 [0.90-1.69],0.1969809415345356
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26960,100,0.87 [0.68-1.09],0.2279325149701904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26926,66,0.80 [0.59-1.07],0.1289493513497011
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27522,65,1.08 [0.82-1.43],0.5689832203975347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27481,96,1.06 [0.85-1.33],0.6082672123633186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27472,87,1.06 [0.83-1.34],0.6443395397377978
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,27293,43,0.85 [0.59-1.21],0.3696496093235878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26677,383,1.01 [0.90-1.14],0.8399972456155401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26438,144,1.02 [0.85-1.23],0.8258886392918467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26540,246,1.03 [0.89-1.19],0.6769647431279922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",23901,30,0.89 [0.58-1.37],0.6091190249984005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",23919,48,0.87 [0.62-1.23],0.4403650241522225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23997,126,0.96 [0.78-1.18],0.7030108288654329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24002,131,0.97 [0.79-1.19],0.7792676778782086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13438,281,0.96 [0.84-1.11],0.6003818934908722
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10741,27,1.20 [0.79-1.84],0.3944487826043332
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23920,49,0.85 [0.60-1.19],0.3321365485404267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25433,798,1.03 [0.95-1.12],0.474461919441984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26475,196,1.05 [0.89-1.23],0.5552233595432292
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27110,77,0.92 [0.70-1.19],0.5230669725027757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27592,71,0.90 [0.68-1.18],0.4414882735655712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,27361,47,1.45 [1.08-1.95],0.0147326313890397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27600,38,0.90 [0.61-1.31],0.5775182901913739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Stomach,27639,31,0.84 [0.55-1.30],0.4382176852322856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,27334,290,1.05 [0.92-1.20],0.4861474041903206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27570,113,1.02 [0.83-1.27],0.8243935280090912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27574,94,1.00 [0.79-1.26],0.9993262670418288
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27540,43,0.97 [0.68-1.37],0.8476607526867233
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",27542,43,0.97 [0.68-1.37],0.8476734378115591
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,27437,242,1.07 [0.92-1.23],0.3848417926734849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27599,111,1.20 [0.98-1.48],0.0832640946389503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,27514,186,0.89 [0.75-1.05],0.1729312423962159
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of breast,15256,94,0.97 [0.77-1.23],0.8305492567170242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,14899,680,1.07 [0.98-1.17],0.1448502369830276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26633,195,1.24 [1.07-1.45],0.0052567342355134
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26530,347,1.02 [0.90-1.15],0.7379767228704257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26530,347,1.02 [0.90-1.15],0.7379767228704257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25326,348,1.10 [0.97-1.24],0.1377522250793619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27178,79,0.85 [0.65-1.11],0.226461708890908
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27380,104,0.96 [0.77-1.20],0.7303353430590496
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24240,688,1.05 [0.96-1.15],0.2428775508409344
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26342,432,0.99 [0.89-1.11],0.8580756239715744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25863,114,0.91 [0.73-1.13],0.3796212953303363
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26895,54,0.87 [0.63-1.20],0.3910452428879314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25848,99,0.93 [0.74-1.17],0.5275710441475414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26072,323,0.97 [0.85-1.10],0.6111180274832887
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26063,314,0.98 [0.86-1.12],0.7592320956916346
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25719,178,0.96 [0.79-1.16],0.6729886213317021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25724,176,0.96 [0.79-1.16],0.6857238115660453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24079,527,1.03 [0.93-1.14],0.5243193534946498
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23625,73,0.99 [0.75-1.29],0.9190342174540485
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24035,483,1.04 [0.93-1.15],0.5236373704711963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23593,41,1.13 [0.80-1.59],0.500930204864751
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23630,78,0.96 [0.74-1.25],0.7870986642814319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,23976,754,1.01 [0.93-1.10],0.816626367114285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23512,290,1.06 [0.93-1.22],0.3935814778920731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27202,222,1.04 [0.89-1.21],0.6290170783218856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27271,158,1.13 [0.95-1.34],0.1803207673860178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25673,81,0.85 [0.65-1.10],0.2200185513576167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27521,81,0.83 [0.64-1.08],0.1736687116631879
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23303,81,0.84 [0.65-1.10],0.2086404300443183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Alcohol dependence,25687,95,1.10 [0.87-1.39],0.4323909107670307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,25653,66,1.21 [0.92-1.60],0.1721672776597242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23293,71,0.78 [0.59-1.04],0.094592728863207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23605,383,1.00 [0.89-1.13],0.9677263181374962
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression,25932,332,1.01 [0.89-1.15],0.853676412871971
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression or dysthymia,23455,289,1.07 [0.93-1.22],0.3417133456281566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23366,144,1.05 [0.87-1.27],0.6078340951870982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Other anxiety disorders,26152,69,0.87 [0.66-1.15],0.3356939136402489
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,24594,1430,1.00 [0.94-1.07],0.910299016404008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22925,157,0.97 [0.81-1.17],0.766506489480605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27437,127,1.01 [0.82-1.23],0.9540740559580484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26314,489,0.96 [0.86-1.06],0.4241692398954911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,25992,167,0.88 [0.73-1.05],0.15209765238139
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,25928,103,0.93 [0.74-1.16],0.5135077873098899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27269,94,0.92 [0.72-1.17],0.4824265218388396
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27155,39,0.81 [0.55-1.19],0.2799341446607852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,25996,171,1.04 [0.87-1.23],0.6751593711340382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,27037,133,1.03 [0.85-1.26],0.733871707231456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26533,610,1.03 [0.94-1.13],0.5247009419325734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26058,135,1.04 [0.86-1.26],0.6776826633084567
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26252,329,0.98 [0.86-1.11],0.7172383681640613
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27424,84,1.00 [0.78-1.29],0.9796507294668289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,27393,53,1.07 [0.79-1.46],0.6516537004230127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,27211,121,0.89 [0.72-1.10],0.2872099788678303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27176,312,0.98 [0.86-1.11],0.74161608040519
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27033,169,0.96 [0.80-1.15],0.6420643748033544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26951,87,0.94 [0.73-1.20],0.6221926338626127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26967,103,0.87 [0.69-1.10],0.2440998799254484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26915,51,1.24 [0.92-1.68],0.1648751449822874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25954,66,1.30 [0.99-1.69],0.0546946993917706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26073,185,1.09 [0.92-1.29],0.3051287540303061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27031,129,1.10 [0.90-1.34],0.3391438422501068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27388,25,1.35 [0.89-2.05],0.1618085704684438
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1716,25,1.22 [0.80-1.88],0.3555736048729795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25697,25,1.35 [0.89-2.05],0.1559801018341617
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27265,49,1.05 [0.76-1.45],0.7559249345292145
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27245,29,0.91 [0.59-1.41],0.6732145578096247
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27178,93,0.81 [0.63-1.04],0.1001665602710422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27219,96,1.05 [0.84-1.32],0.6586485317874728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27516,122,1.20 [0.99-1.46],0.0677429601987475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27123,92,1.16 [0.92-1.45],0.2036523632298447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21651,1944,1.05 [0.99-1.11],0.1241634266315484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27316,40,0.68 [0.46-1.01],0.0538197617255935
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22689,1296,1.03 [0.96-1.11],0.3642880539213181
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,22713,1320,1.03 [0.97-1.11],0.3375160734676854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21441,48,0.96 [0.69-1.33],0.804238320278907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26149,563,0.97 [0.88-1.07],0.5975385639260027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,25933,347,0.93 [0.82-1.05],0.2338600082761845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26932,135,0.90 [0.74-1.10],0.3016403716056438
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27053,256,0.92 [0.80-1.07],0.2794629367237558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27533,56,0.91 [0.67-1.24],0.5616932974680522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25742,156,0.93 [0.77-1.12],0.4500739945892306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25994,418,0.99 [0.88-1.10],0.7978902204170506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27125,79,1.14 [0.89-1.46],0.304038491338551
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27117,175,0.99 [0.83-1.18],0.9157988583926802
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27107,61,0.98 [0.73-1.31],0.8901979458312457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27108,62,1.00 [0.75-1.33],0.9850267363929008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21452,59,1.00 [0.75-1.35],0.9770587229239232
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25054,46,0.84 [0.59-1.19],0.3294403285290027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,25080,72,1.11 [0.85-1.44],0.4391303991583711
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,18894,91,1.23 [0.99-1.55],0.0673198754074176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18991,188,1.03 [0.87-1.22],0.7066259234561348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,25048,40,1.51 [1.10-2.08],0.0111601952387545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25069,61,1.00 [0.75-1.35],0.9798966815854228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27144,119,1.14 [0.93-1.40],0.1987947403971806
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27108,112,0.99 [0.80-1.23],0.953777973566447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27140,83,1.06 [0.83-1.36],0.649384453770609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27188,72,1.07 [0.82-1.39],0.6233942843074238
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26917,50,1.01 [0.74-1.39],0.9462574882074984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26950,83,0.97 [0.76-1.25],0.8178050490035556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26417,115,0.99 [0.80-1.22],0.89865084311459
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26397,95,1.02 [0.81-1.28],0.8846762526581364
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27472,91,1.02 [0.81-1.29],0.8630295319488569
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,26732,430,0.87 [0.78-0.98],0.0212216921484737
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,26909,55,0.85 [0.61-1.16],0.3009151615917679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23406,1902,1.05 [1.00-1.11],0.0549320972822157
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27414,135,1.03 [0.85-1.24],0.7933513930945404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26459,184,1.09 [0.92-1.29],0.3059982001477459
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26433,158,1.06 [0.89-1.27],0.5086827111653378
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27044,207,0.96 [0.82-1.13],0.6603134550367974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27042,205,0.95 [0.81-1.12],0.5644050886732614
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26763,652,1.07 [0.98-1.17],0.1537051089375864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,26203,92,1.30 [1.04-1.63],0.0190987014720739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,1.08 [0.87-1.33],0.5048044748567988
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26528,417,1.07 [0.96-1.20],0.2202649432743173
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,26332,221,1.16 [1.00-1.34],0.0495505529170942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15928,50,0.85 [0.61-1.20],0.3536524864008236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25311,856,1.04 [0.96-1.12],0.3666448620012296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,26931,104,0.92 [0.73-1.16],0.48976151572572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26931,104,0.92 [0.73-1.16],0.48976151572572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26931,104,0.92 [0.73-1.16],0.48976151572572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25911,779,1.04 [0.96-1.13],0.3813023524952986
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Asthma,21172,779,1.05 [0.96-1.14],0.2793257814564509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21033,779,1.05 [0.96-1.14],0.2876277073179055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21157,764,1.04 [0.96-1.13],0.3215914938516683
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27454,55,1.02 [0.75-1.38],0.9112863061847376
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,26334,42,1.01 [0.72-1.44],0.9348016917827764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27514,42,1.02 [0.72-1.44],0.9159815348356924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26327,35,0.90 [0.61-1.33],0.5978683934903324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,26322,75,1.09 [0.84-1.40],0.5247784872299128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,26424,177,1.17 [0.99-1.38],0.0629783059224188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26809,83,1.36 [1.08-1.71],0.008387022731702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19573,5063,1.01 [0.97-1.05],0.5329579853276192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27046,491,1.01 [0.92-1.12],0.7905119294384679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27569,141,1.01 [0.84-1.23],0.8806508600019199
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,27575,132,1.03 [0.84-1.25],0.7839746866574837
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,26676,121,1.00 [0.81-1.22],0.9659036832390374
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26661,106,1.01 [0.81-1.26],0.9328289900474844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27555,156,1.06 [0.88-1.26],0.5520339221014224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26648,93,1.04 [0.83-1.32],0.7122570393572327
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26397,65,0.97 [0.73-1.29],0.8440394440393548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27517,45,0.82 [0.58-1.17],0.2802879012643382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22233,198,1.03 [0.87-1.21],0.7403388856853541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23753,1718,1.02 [0.97-1.08],0.3970588343006266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,22300,265,1.16 [1.02-1.33],0.0280134143758047
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22582,547,0.98 [0.89-1.08],0.6684646075037557
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22101,66,1.05 [0.80-1.39],0.7059196219902907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22164,129,1.01 [0.83-1.23],0.9170916272986318
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22067,32,1.45 [1.01-2.07],0.0418797137709949
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,22136,101,0.97 [0.77-1.21],0.7600906295541162
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,22134,99,1.01 [0.81-1.28],0.8992563548137908
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27535,70,1.04 [0.80-1.37],0.7487760916751989
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,22136,101,0.95 [0.75-1.19],0.6307756205104667
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22665,630,1.10 [1.00-1.20],0.0437136412250419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,27448,159,0.92 [0.76-1.10],0.359720214860543
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,22415,380,0.97 [0.86-1.09],0.6365876599085255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22151,116,0.93 [0.75-1.15],0.5104048669837262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27441,184,0.89 [0.75-1.05],0.1709559387140795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,27413,124,0.90 [0.73-1.11],0.3240880914312821
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,24914,1155,1.05 [0.98-1.12],0.1826613433448582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,24147,388,1.07 [0.96-1.21],0.2176760507781368
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,23877,118,0.94 [0.76-1.16],0.5398784988368721
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,23854,95,0.96 [0.76-1.22],0.7340249829034659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24345,586,1.06 [0.97-1.17],0.2146802282389832
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26766,741,1.09 [1.00-1.18],0.0418919695641275
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,22752,1641,0.98 [0.92-1.04],0.5104542956519671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27305,70,1.17 [0.91-1.52],0.2227400578251572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27553,100,1.17 [0.94-1.46],0.1497768864662667
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,26125,100,1.18 [0.95-1.46],0.1411485149704178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26101,76,1.15 [0.89-1.47],0.2801179514043675
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27505,133,1.04 [0.86-1.26],0.6980550192945083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,26158,133,1.04 [0.86-1.27],0.682304000337605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26140,115,1.03 [0.84-1.27],0.7708762852755613
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26614,589,1.10 [1.00-1.21],0.0393947299855065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26609,584,1.10 [1.01-1.21],0.0355639478761071
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21181,70,1.11 [0.85-1.45],0.4362904803668931
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal stricture,27303,70,1.11 [0.85-1.44],0.4564076127989691
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21159,48,1.12 [0.81-1.54],0.4955141178761005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21407,296,1.03 [0.90-1.18],0.6585863723031276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21285,174,0.91 [0.76-1.09],0.2924160548020564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21358,247,1.10 [0.96-1.27],0.1740132527193774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,26478,221,1.08 [0.93-1.26],0.3159790945139819
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27226,83,0.95 [0.74-1.23],0.7160957633651173
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21285,174,0.89 [0.75-1.06],0.1949977682335526
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21196,85,0.92 [0.72-1.19],0.5305354072946578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21886,775,1.00 [0.92-1.08],0.9461046530298276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,21289,178,0.88 [0.74-1.05],0.1593271663304363
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27214,71,0.89 [0.67-1.17],0.3931925575298687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,26904,118,0.72 [0.58-0.91],0.0047932863136947
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,26851,65,0.72 [0.53-0.97],0.0325849525537467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26417,513,1.00 [0.90-1.11],0.9776048582181532
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,26310,406,0.99 [0.88-1.11],0.8226482574969812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,25981,77,1.17 [0.91-1.50],0.2143048892666003
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25947,43,0.92 [0.64-1.31],0.632129343654038
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,25963,59,0.85 [0.63-1.16],0.31857683611229
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27474,59,0.86 [0.63-1.17],0.3248380214502065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26395,275,1.13 [0.99-1.30],0.0671030219558307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26185,65,1.02 [0.77-1.35],0.8963773223075033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,26171,51,0.99 [0.72-1.37],0.9622861885725223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26161,41,1.31 [0.94-1.82],0.1130033964788477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26296,176,1.16 [0.98-1.37],0.0768614151003609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,26291,171,1.16 [0.98-1.37],0.0813012553738332
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25067,1469,0.96 [0.91-1.03],0.2479969930838517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27258,99,1.03 [0.82-1.29],0.8024481147421982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27206,461,0.96 [0.86-1.07],0.483307451478473
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26542,528,0.95 [0.86-1.05],0.3365004370699115
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26864,388,1.00 [0.89-1.12],0.9836289877214256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26580,104,0.93 [0.74-1.17],0.5428055057659165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26695,219,1.04 [0.89-1.21],0.6271901092425444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27383,85,0.99 [0.78-1.27],0.960674523377302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27369,71,1.00 [0.77-1.31],0.9799330457539924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27348,50,0.98 [0.71-1.35],0.8938810705192733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27467,33,0.69 [0.44-1.06],0.0878166371991429
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27464,30,0.67 [0.42-1.05],0.0800563110917639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26807,62,1.05 [0.79-1.40],0.7135129034239143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27097,352,0.96 [0.85-1.08],0.4724673241607141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26083,69,0.94 [0.72-1.25],0.6867270112595387
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26111,97,0.83 [0.65-1.06],0.1328961774987623
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26096,82,0.82 [0.63-1.07],0.1445566990111626
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26223,209,1.04 [0.89-1.22],0.6012089764275249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26194,180,0.99 [0.83-1.18],0.912099502991818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21400,3454,1.03 [0.99-1.07],0.1889407932571193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22990,1825,1.01 [0.96-1.07],0.6199894398336223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25234,1093,1.09 [1.02-1.17],0.0123734578557346
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21282,117,1.04 [0.84-1.28],0.7345809345332133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21500,335,0.99 [0.87-1.12],0.8878955064688873
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27304,111,1.05 [0.85-1.30],0.6474287682890264
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27320,99,1.03 [0.82-1.29],0.7947961251174469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21808,643,0.99 [0.90-1.09],0.8294413043580462
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24356,643,0.98 [0.89-1.08],0.6963785241462632
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21208,43,1.17 [0.84-1.65],0.350751972013913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27253,42,1.13 [0.80-1.60],0.4711867860692108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21315,150,0.91 [0.75-1.10],0.3325713572690147
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21189,24,1.16 [0.74-1.82],0.5073351386911507
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21288,123,0.86 [0.70-1.07],0.1834373963066541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27526,60,0.82 [0.60-1.12],0.2128239392922017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21487,322,1.01 [0.89-1.15],0.8433455350730521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21382,217,1.01 [0.86-1.18],0.9143208139501344
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22378,1213,1.02 [0.96-1.09],0.5251881726567401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21200,35,0.85 [0.57-1.27],0.4254280531314257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21333,168,0.92 [0.77-1.10],0.3666022612877271
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21200,35,1.47 [1.04-2.08],0.0286165668852754
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21192,27,0.76 [0.48-1.22],0.2626397321188748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21681,516,1.06 [0.96-1.17],0.2702009988512186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21593,428,1.07 [0.96-1.19],0.2259512540227142
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21884,277,0.97 [0.85-1.12],0.6926769475173286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27251,151,0.87 [0.72-1.05],0.1508096626647884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27139,39,0.75 [0.51-1.10],0.1427388453855337
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24720,49,0.94 [0.68-1.32],0.7354571912796046
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24885,214,0.92 [0.78-1.08],0.3055052741603901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25555,884,0.97 [0.89-1.05],0.3991007658198304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24805,134,1.03 [0.84-1.25],0.7828676418831652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24726,55,0.72 [0.52-1.00],0.0482549777134864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25415,744,0.98 [0.90-1.06],0.6030016992084175
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24729,58,1.04 [0.78-1.40],0.7748946796688003
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24914,243,1.03 [0.89-1.19],0.6626135837841539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24780,109,1.04 [0.84-1.29],0.7069593425325404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24738,67,0.94 [0.71-1.24],0.6489633057235515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24817,146,0.89 [0.73-1.08],0.2207241176631589
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24735,64,0.99 [0.75-1.32],0.967497454647861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24988,317,1.02 [0.89-1.16],0.7914137256284917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24427,286,1.03 [0.90-1.18],0.6391074745979761
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24195,54,nan [nan-nan],
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24195,54,1.05 [0.78-1.43],0.7351318564017207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24257,116,1.07 [0.87-1.32],0.5310339143952615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24197,56,1.16 [0.87-1.56],0.3105086079132354
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24203,62,1.36 [1.04-1.78],0.022413165605813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24189,48,1.30 [0.96-1.78],0.0909980893578444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24365,224,1.00 [0.85-1.16],0.9618690756440628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24192,51,0.93 [0.67-1.29],0.6672420408513465
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24196,55,1.20 [0.89-1.61],0.235201622176508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24249,108,1.02 [0.82-1.27],0.8844120926429355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24213,72,0.84 [0.63-1.10],0.2060167787279428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24564,423,1.10 [0.99-1.23],0.0816291233859121
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24285,144,1.05 [0.87-1.26],0.6393411629172729
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24357,216,1.16 [1.00-1.34],0.0570697544003187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26274,97,0.95 [0.75-1.21],0.6816138944236685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26512,335,0.94 [0.83-1.07],0.3548421969140788
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26232,55,1.04 [0.77-1.41],0.7778825855677236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26246,69,0.85 [0.64-1.12],0.2471401905502002
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26292,115,0.93 [0.75-1.15],0.5090207161204059
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23345,4326,0.96 [0.93-1.00],0.0689060398352936
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11187,407,0.99 [0.88-1.12],0.9110283055891408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26131,207,0.93 [0.79-1.09],0.3840506536055236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25978,54,0.86 [0.62-1.18],0.3471125623274373
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26279,43,0.99 [0.70-1.40],0.9585165395138106
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26284,48,1.04 [0.75-1.44],0.8159825409748808
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26290,54,0.96 [0.70-1.31],0.7920523669273476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27260,232,0.95 [0.82-1.11],0.5212617798102418
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27334,51,0.98 [0.71-1.35],0.9039949631565836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27190,162,0.96 [0.80-1.15],0.645520216873578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27119,91,1.03 [0.82-1.31],0.7807281061586592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26127,863,0.92 [0.85-1.00],0.0545620040954845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,25342,78,0.95 [0.73-1.24],0.7135355378896875
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25331,67,0.92 [0.69-1.22],0.5730834401208201
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25440,176,0.96 [0.81-1.15],0.6813499065911615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25350,86,1.02 [0.80-1.30],0.8912162962295309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25871,607,0.93 [0.85-1.03],0.1606958813456476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10849,69,1.16 [0.89-1.52],0.2617880377926994
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10816,36,0.85 [0.57-1.26],0.4159390969424553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,10818,38,1.07 [0.75-1.55],0.6980017998462897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10873,93,1.12 [0.89-1.40],0.3433951044007672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10847,67,1.22 [0.94-1.60],0.1398502311802919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10881,101,0.86 [0.68-1.09],0.20312682150016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15108,246,1.01 [0.87-1.16],0.9452327184429672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14933,71,1.09 [0.84-1.42],0.5161851848522307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,14951,89,1.06 [0.84-1.35],0.6142142340841665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14915,53,0.87 [0.63-1.20],0.3950768705684069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15076,381,0.95 [0.84-1.07],0.3757005039538935
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,14776,81,0.88 [0.68-1.14],0.3178180801898267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14883,188,1.03 [0.87-1.21],0.7541587237095684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13893,2735,1.01 [0.96-1.06],0.6242273536575103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,11454,296,1.15 [1.01-1.31],0.0367403265820463
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11249,91,1.36 [1.08-1.70],0.0078360366518404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11271,113,1.11 [0.90-1.37],0.3310553098259955
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11459,301,0.96 [0.84-1.10],0.6008509486847322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11461,303,0.98 [0.86-1.12],0.7801146156266932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11624,466,1.00 [0.90-1.11],0.9854276493088128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11320,162,1.12 [0.94-1.33],0.2195756685131352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11375,217,1.07 [0.92-1.25],0.3746064186827481
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11236,78,0.99 [0.76-1.28],0.9326550519608764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11296,138,1.05 [0.87-1.28],0.6122095209922402
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15261,198,1.15 [0.98-1.35],0.0837851706891798
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15269,189,1.13 [0.96-1.33],0.1354006406499719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15288,109,1.22 [0.99-1.50],0.0620353791448241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15281,119,1.24 [1.01-1.51],0.0359935540393104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11230,72,1.02 [0.78-1.33],0.8934215719114871
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11220,62,1.01 [0.76-1.35],0.9256530302441824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11233,75,0.81 [0.62-1.07],0.1416332526901896
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,15185,374,1.13 [1.01-1.27],0.0330481975024908
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12285,1127,1.07 [0.99-1.14],0.0744946275518117
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11929,771,1.05 [0.97-1.14],0.2408875661420647
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15268,155,1.03 [0.86-1.24],0.7325816305970071
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11507,349,0.97 [0.86-1.10],0.6310494182051862
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11436,278,0.94 [0.82-1.08],0.3771653524394436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11419,261,1.03 [0.89-1.19],0.6601596828173224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female infertility,11273,115,0.99 [0.80-1.23],0.9245057660196822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11266,108,0.97 [0.78-1.22],0.8039663932063804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15281,863,1.01 [0.93-1.10],0.8555866026843817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15287,1171,0.98 [0.91-1.06],0.5937928287099404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15283,462,1.01 [0.90-1.12],0.8947858869631866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,14952,131,1.08 [0.89-1.32],0.4461459487907904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15009,188,0.94 [0.79-1.11],0.4570646148902813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,14976,155,0.98 [0.81-1.18],0.8314634265092632
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15301,164,0.97 [0.81-1.17],0.7765028958679523
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15303,161,0.97 [0.81-1.17],0.7677639834245873
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15298,405,0.89 [0.79-1.01],0.0696606401406942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15011,118,0.75 [0.60-0.94],0.0133657369913149
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15120,227,0.88 [0.75-1.03],0.1088356331931825
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14563,145,1.10 [0.91-1.33],0.3222287358416793
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14614,196,0.92 [0.78-1.10],0.3573237773281902
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14666,248,1.03 [0.88-1.19],0.7281432133009451
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14562,144,1.10 [0.91-1.34],0.3135169924824641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14553,135,1.09 [0.90-1.33],0.3755361243577371
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14567,149,0.87 [0.72-1.06],0.1793541479609064
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14343,227,1.01 [0.86-1.18],0.9105650649599184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14539,423,0.93 [0.82-1.04],0.2012421887961073
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14766,650,1.00 [0.91-1.11],0.9622652392085804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15304,165,1.03 [0.86-1.23],0.7433438077296559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13876,126,0.98 [0.80-1.20],0.8397149809151282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14215,99,0.95 [0.75-1.20],0.6680909467060777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15311,332,0.92 [0.81-1.05],0.218765732861631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15230,251,0.84 [0.72-0.98],0.0276678658891848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15298,247,1.05 [0.91-1.22],0.4927942359347236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15289,238,1.04 [0.89-1.21],0.604759011983155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27392,34,1.04 [0.71-1.53],0.8449617364297315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26004,513,0.89 [0.80-0.99],0.0247917298270613
